Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.

by Yasushi Suzuki, Takato Odagiri, Masato Tashiro, Eri Nobusawa
Published 2016-01-01

Cell-Based Influenza A/H1N1pdm09 Vaccine Viruses Containing Chimeric Hemagglutinin with Improved Membrane Fusion Ability

by Madoka Kawahara, Toshiya Wada, Fumitaka Momose, Eri Nobusawa, Yuko Morikawa
Published 2020-08-01

Host Adaptation and the Alteration of Viral Properties of the First Influenza A/H1N1pdm09 Virus Isolated in Japan.

by Akira Ainai, Hideki Hasegawa, Masatsugu Obuchi, Takato Odagiri, Makoto Ujike, Masayuki Shirakura, Eri Nobusawa, Masato Tashiro, Hideki Asanuma
Published 2015-01-01

Low response in eliciting neuraminidase inhibition activity of sera among recipients of a split, monovalent pandemic influenza vaccine during the 2009 pandemic.

by Hiroko Ito, Hidekazu Nishimura, Tomoko Kisu, Haruhisa Hagiwara, Oshi Watanabe, Francois Marie Ngako Kadji, Ko Sato, Suguru Omiya, Emi Takashita, Eri Nobusawa
Published 2020-01-01

A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines

by Yamato Wada, Arnone Nithichanon, Eri Nobusawa, Leonard Moise, William D. Martin, Norio Yamamoto, Kazutaka Terahara, Haruhisa Hagiwara, Takato Odagiri, Masato Tashiro, Ganjana Lertmemongkolchai, Haruko Takeyama, Anne S. De Groot, Manabu Ato, Yoshimasa Takahashi
Published 2017-04-01